Lisdexamfetamine (Vyvanse)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lisdexamfetamine (Vyvanse), covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment [Phase 3]